These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2059 related items for PubMed ID: 23973293

  • 1. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
    McClean PL, Hölscher C.
    Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease.
    McClean PL, Parthsarathy V, Faivre E, Hölscher C.
    J Neurosci; 2011 Apr 27; 31(17):6587-94. PubMed ID: 21525299
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prophylactic liraglutide treatment prevents amyloid plaque deposition, chronic inflammation and memory impairment in APP/PS1 mice.
    McClean PL, Jalewa J, Hölscher C.
    Behav Brain Res; 2015 Oct 15; 293():96-106. PubMed ID: 26205827
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. D-Ala2GIP facilitated synaptic plasticity and reduces plaque load in aged wild type mice and in an Alzheimer's disease mouse model.
    Faivre E, Hölscher C.
    J Alzheimers Dis; 2013 Oct 15; 35(2):267-83. PubMed ID: 23568101
    [Abstract] [Full Text] [Related]

  • 8. Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP/PS1 mice.
    Gengler S, McClean PL, McCurtin R, Gault VA, Hölscher C.
    Neurobiol Aging; 2012 Feb 15; 33(2):265-76. PubMed ID: 20359773
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The diabetes drug liraglutide ameliorates aberrant insulin receptor localisation and signalling in parallel with decreasing both amyloid-β plaque and glial pathology in a mouse model of Alzheimer's disease.
    Long-Smith CM, Manning S, McClean PL, Coakley MF, O'Halloran DJ, Holscher C, O'Neill C.
    Neuromolecular Med; 2013 Mar 15; 15(1):102-14. PubMed ID: 23011726
    [Abstract] [Full Text] [Related]

  • 13. The incretin hormones glucagonlike peptide 1 and glucose-dependent insulinotropic polypeptide are neuroprotective in mouse models of Alzheimer's disease.
    Hölscher C.
    Alzheimers Dement; 2014 Feb 15; 10(1 Suppl):S47-54. PubMed ID: 24529525
    [Abstract] [Full Text] [Related]

  • 14. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
    Trinchese F, Liu S, Battaglia F, Walter S, Mathews PM, Arancio O.
    Ann Neurol; 2004 Jun 15; 55(6):801-14. PubMed ID: 15174014
    [Abstract] [Full Text] [Related]

  • 15. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
    Gu XH, Xu LJ, Liu ZQ, Wei B, Yang YJ, Xu GG, Yin XP, Wang W.
    Behav Brain Res; 2016 Sep 15; 311():309-321. PubMed ID: 27233830
    [Abstract] [Full Text] [Related]

  • 16. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
    Lok K, Zhao H, Zhang C, He N, Shen H, Wang Z, Zhao W, Yin M.
    J Neurol Sci; 2013 Dec 15; 335(1-2):145-54. PubMed ID: 24095271
    [Abstract] [Full Text] [Related]

  • 17. Impairment of Spike-Timing-Dependent Plasticity at Schaffer Collateral-CA1 Synapses in Adult APP/PS1 Mice Depends on Proximity of Aβ Plaques.
    Garad M, Edelmann E, Leßmann V.
    Int J Mol Sci; 2021 Jan 30; 22(3):. PubMed ID: 33573114
    [Abstract] [Full Text] [Related]

  • 18. The effect of ageing on neurogenesis and oxidative stress in the APP(swe)/PS1(deltaE9) mouse model of Alzheimer's disease.
    Hamilton A, Holscher C.
    Brain Res; 2012 Apr 17; 1449():83-93. PubMed ID: 22418058
    [Abstract] [Full Text] [Related]

  • 19. Cholinergic degeneration is associated with increased plaque deposition and cognitive impairment in APPswe/PS1dE9 mice.
    Laursen B, Mørk A, Plath N, Kristiansen U, Bastlund JF.
    Behav Brain Res; 2013 Mar 01; 240():146-52. PubMed ID: 23178660
    [Abstract] [Full Text] [Related]

  • 20. Colivelin Ameliorates Impairments in Cognitive Behaviors and Synaptic Plasticity in APP/PS1 Transgenic Mice.
    Wu M, Shi H, He Y, Yuan L, Qu X, Zhang J, Wang Z, Cai H, Qi J.
    J Alzheimers Dis; 2017 Mar 01; 59(3):1067-1078. PubMed ID: 28731445
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 103.